Financial Gravity Asset Management, Inc. Ocuphire Pharma, Inc. Transaction History
Financial Gravity Asset Management, Inc.
- $459 Billion
- Q1 2025
A detailed history of Financial Gravity Asset Management, Inc. transactions in Ocuphire Pharma, Inc. stock. As of the latest transaction made, Financial Gravity Asset Management, Inc. holds 16,555 shares of OCUP stock, worth $16,223. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,555Holding current value
$16,223% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding OCUP
# of Institutions
50Shares Held
14.6MCall Options Held
13.7KPut Options Held
1K-
Perceptive Advisors LLC New York, NY4.33MShares$4.24 Million0.18% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.16MShares$3.09 Million0.14% of portfolio
-
Opaleye Management Inc. Boston, MA1.18MShares$1.15 Million0.32% of portfolio
-
Bios Capital Management, LP Fort Worth, TX995KShares$975,3441.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA992KShares$972,3560.0% of portfolio
About Ocuphire Pharma, Inc.
- Ticker OCUP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,579,800
- Market Cap $20.2M
- Description
- Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...